rs193922329
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000162.5(GCK):c.76C>T(p.Gln26*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000162.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCK | NM_000162.5 | c.76C>T | p.Gln26* | stop_gained | Exon 2 of 10 | ENST00000403799.8 | NP_000153.1 | |
GCK | NM_033507.3 | c.79C>T | p.Gln27* | stop_gained | Exon 2 of 10 | NP_277042.1 | ||
GCK | NM_033508.3 | c.73C>T | p.Gln25* | stop_gained | Exon 3 of 11 | NP_277043.1 | ||
GCK | NM_001354800.1 | c.76C>T | p.Gln26* | stop_gained | Exon 2 of 11 | NP_001341729.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461734Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 727162
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:4
This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with maturity-onset diabetes of the young (PMID: 24735133, 11508276, 24804978, 28726111). ClinVar contains an entry for this variant (Variation ID: 36256). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Gln26*) in the GCK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GCK are known to be pathogenic (PMID: 24323243). -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 14981344, 25525159, 35472491, 36257325, 36504295, 36208030, 35177841, 11508276, 24735133) -
- -
- -
Maturity-onset diabetes of the young type 2 Pathogenic:3
This is a nonsense variant in the GCK gene, where loss of function is a known mechanism of disease (PVS1). This variant results in a truncated protein by creating a premature stop codon. It is not present in population databases (GnomAD exomes, GnomAD genomes) (PM2). -
- -
PVS1, PM2, PP1, PS4 -
GCK-related disorder Pathogenic:1
The GCK c.76C>T variant is predicted to result in premature protein termination (p.Gln26*). This variant has been reported in several individuals with maturity-onset diabetes of the young (MODY) (Massa et al. 2001. PubMed ID: 11508276; Costantini et al. 2014. PubMed ID: 24735133; Table S1, Mirshahi et al. 2022. PubMed ID: 36257325; Yorifuji et al. 2022. PubMed ID: 36504295), in an individual with type 2 diabetes (Table S6, Jurgens et al. 2022. PubMed ID: 35177841), and in three individuals with monogenic diabetes (Vaxillaire et al. 2020. PubMed ID: 33242514). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in GCK are expected to be pathogenic. This variant is interpreted as pathogenic. -
Maturity onset diabetes mellitus in young Pathogenic:1
Potent mutations in GCK gene is associated with poor secretion of insulin. Its associated with milder forms of diabetes, which can be controlled by diet . However, there is no sufficient evidence to ascertain the significance of rs193922329 in MODY, yet. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at